Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
- 1 April 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (7), 2970-2974
- https://doi.org/10.1073/pnas.89.7.2970
Abstract
2-Chlorodeoxyadenosine (CdA) is active in chronic lymphocytic leukemia, hairy-cell leukemia, and low-grade lymphomas. In part, this spectrum of activity may be attributable to the selective toxicity of CdA to nondividing lymphocytes and monocytes. However, CdA is unstable at acidic pH and is degraded by bacterial nucleoside phosphorylases. The present experiments demonstrate that the 2'-arabino-fluoro derivative of CdA, designated CAFdA, is also directly toxic to quiescent lymphocytes and macrophages. Unlike CdA, CAFdA was stable at pH 2 and resisted degradation by Escherichia coli nucleoside phosphorylase. Cell killing was preceded by the formation of DNA strand breaks and could be prevented by supplementation of the medium with deoxycytidine. The initial DNA damage initiated the pattern of oligonucleosomal DNA fragmentation characteristic of apoptosis. Mutant lymphoblasts, deficient in deoxycytidine kinase, with elevated cytoplasmic 5'-nucleotidase, or with expanded deoxynucleotide pools secondary to increased ribonucleotide reductase activity, were cross-resistant to both CAFdA and CdA toxicity. One-week oral treatment with CAFdA (1 mg/ml in drinking water) achieved an average plasma concentration of 0.56 microM and eliminated 90% of chronic lymphocytic leukemia cells transplanted into severe combined immunodeficiency (scid) mice. Under the same conditions, CdA was much less active. Collectively, these results suggest that CAFdA could be effective as an oral agent in indolent lymphoproliferative diseases and in autoimmune diseases where lymphocyte and monocyte depletion is desirable.Keywords
This publication has 28 references indexed in Scilit:
- Deoxyadenosine-resistant human T lymphoblasts with elevated 5′-nucleotidase activityBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
- Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.Journal of Clinical Oncology, 1991
- Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.JCI Insight, 1990
- Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patientsEuropean Journal of Immunology, 1990
- New perspectives on the pathogenesis of rheumatoid arthritisAmerican Journal Of Medicine, 1988
- The SCID-hu Mouse: Murine Model for the Analysis of Human Hematolymphoid Differentiation and FunctionScience, 1988
- 2-CHLORODEOXYADENOSINE - AN EFFECTIVE NEW AGENT FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA1988
- 2',3'-Dideoxy-2'-fluoro-ara-a. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)Biochemical Pharmacology, 1987
- Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.JCI Insight, 1985
- SPECIFIC TOXICITY OF 2-CHLORODEOXYADENOSINE TOWARD RESTING AND PROLIFERATING HUMAN-LYMPHOCYTES1983